102 related articles for article (PubMed ID: 18787051)
1. Bone turnover and metabolism in paediatric patients with inflammatory bowel disease treated with systemic glucocorticoids.
Vihinen MK; Kolho KL; Ashorn M; Verkasalo M; Raivio T
Eur J Endocrinol; 2008 Dec; 159(6):693-8. PubMed ID: 18787051
[TBL] [Abstract][Full Text] [Related]
2. IL-6 may modulate the skeletal response to glucocorticoids during exacerbations of inflammatory bowel disease.
Kriel M; Sayers A; Fraser WD; Williams AM; Koch A; Zacharowski K; Probert CS; Tobias JH
Calcif Tissue Int; 2010 May; 86(5):375-81. PubMed ID: 20229252
[TBL] [Abstract][Full Text] [Related]
3. Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women.
Garnero P; Tsouderos Y; Marton I; Pelissier C; Varin C; Delmas PD
J Clin Endocrinol Metab; 1999 Jul; 84(7):2390-7. PubMed ID: 10404809
[TBL] [Abstract][Full Text] [Related]
4. The role of cytokines in the changes in bone turnover following bone marrow transplantation.
Lee WY; Kang MI; Oh ES; Oh KW; Han JH; Cha BY; Lee KW; Son HY; Kang SK; Kim CC
Osteoporos Int; 2002 Jan; 13(1):62-8. PubMed ID: 11878457
[TBL] [Abstract][Full Text] [Related]
5. Markers of type I and type III collagen turnover, insulin-like growth factors, and their binding proteins in cord plasma of small premature infants: relationships with fetal growth, gestational age, preeclampsia, and antenatal glucocorticoid treatment.
Kajantie E; Hytinantti T; Koistinen R; Risteli J; Rutanen EM; Seppälä M; Andersson S
Pediatr Res; 2001 Apr; 49(4):481-9. PubMed ID: 11264430
[TBL] [Abstract][Full Text] [Related]
6. Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia.
Crofton PM; Ahmed SF; Wade JC; Stephen R; Elmlinger MW; Ranke MB; Kelnar CJ; Wallace WH
J Clin Endocrinol Metab; 1998 Sep; 83(9):3121-9. PubMed ID: 9745414
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T
Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
[TBL] [Abstract][Full Text] [Related]
8. Effects of a 16-week progressive high-intensity strength training (HIST) on indexes of bone turnover in men over 65 years: a randomized controlled study.
Sartorio A; Lafortuna C; Capodaglio P; Vangeli V; Narici MV; Faglia G
J Endocrinol Invest; 2001 Dec; 24(11):882-6. PubMed ID: 11817713
[TBL] [Abstract][Full Text] [Related]
9. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa.
Grinspoon S; Baum H; Lee K; Anderson E; Herzog D; Klibanski A
J Clin Endocrinol Metab; 1996 Nov; 81(11):3864-70. PubMed ID: 8923830
[TBL] [Abstract][Full Text] [Related]
10. The impact of different glucocorticoid replacement schedules on bone turnover and insulin sensitivity in patients with adrenal insufficiency.
Suliman AM; Freaney R; Smith TP; McBrinn Y; Murray B; McKenna TJ
Clin Endocrinol (Oxf); 2003 Sep; 59(3):380-7. PubMed ID: 12919163
[TBL] [Abstract][Full Text] [Related]
11. The relationship between the GH/IGF-I axis and serum markers of bone turnover metabolism in healthy children.
Léger J; Mercat I; Alberti C; Chevenne D; Armoogum P; Tichet J; Czernichow P
Eur J Endocrinol; 2007 Nov; 157(5):685-92. PubMed ID: 17984250
[TBL] [Abstract][Full Text] [Related]
12. A 1-year prospective study of the effect of infliximab on bone metabolism in inflammatory bowel disease patients.
Veerappan SG; Healy M; Walsh B; O'Morain CA; Daly JS; Ryan BM
Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1335-44. PubMed ID: 27508327
[TBL] [Abstract][Full Text] [Related]
13. Altered bone metabolism in inflammatory bowel disease.
Bischoff SC; Herrmann A; Göke M; Manns MP; von zur Mühlen A; Brabant G
Am J Gastroenterol; 1997 Jul; 92(7):1157-63. PubMed ID: 9219790
[TBL] [Abstract][Full Text] [Related]
14. The association between insulin-like growth factor I and bone turnover markers in the general adult population.
Niemann I; Hannemann A; Nauck M; Spielhagen C; Völzke H; Wallaschofski H; Friedrich N
Bone; 2013 Sep; 56(1):184-90. PubMed ID: 23792936
[TBL] [Abstract][Full Text] [Related]
15. Prospective follow-up of novel markers of bone turnover in persistent asthmatics exposed to low and high doses of inhaled ciclesonide over 12 months.
Anderson WJ; McFarlane LC; Lipworth BJ
J Clin Endocrinol Metab; 2012 Jun; 97(6):1929-36. PubMed ID: 22438232
[TBL] [Abstract][Full Text] [Related]
16. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.
Kolho KL; Raivio T; Lindahl H; Savilahti E
Scand J Gastroenterol; 2006 Jun; 41(6):720-5. PubMed ID: 16716972
[TBL] [Abstract][Full Text] [Related]
17. Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. The MK-677 Study Group.
Murphy MG; Bach MA; Plotkin D; Bolognese J; Ng J; Krupa D; Cerchio K; Gertz BJ
J Bone Miner Res; 1999 Jul; 14(7):1182-8. PubMed ID: 10404019
[TBL] [Abstract][Full Text] [Related]
18. Analysis of bone mineral density and turnover in patients with cystic fibrosis: associations between the IGF system and inflammatory cytokines.
Street ME; Spaggiari C; Ziveri MA; Volta C; Federico G; Baroncelli GI; Bernasconi S; Saggese G
Horm Res; 2006; 66(4):162-8. PubMed ID: 16804317
[TBL] [Abstract][Full Text] [Related]
19. Short-term effects on linear growth and bone turnover in children randomized to receive prednisolone or dexamethasone.
Ahmed SF; Tucker P; Mushtaq T; Wallace AM; Williams DM; Hughes IA
Clin Endocrinol (Oxf); 2002 Aug; 57(2):185-91. PubMed ID: 12153596
[TBL] [Abstract][Full Text] [Related]
20. The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia.
Girgis R; Winter JS
J Clin Endocrinol Metab; 1997 Dec; 82(12):3926-9. PubMed ID: 9398689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
